The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial. [PDF]
J UrolHsieh MH, Hwang JC, Su TH, Lau HH.
europepmc +1 more source
Sustainable UV approaches backed by one step extraction procedure for quantifying the newly released mirabegron and silodosin mixture in urine. [PDF]
Sci RepMohamed AR, El-Hanboushy S, Darweish E.
europepmc +1 more source
Comparison of efficacy and safety of mirabegron and vibegron in the treatment of Overactive Bladder (OAB) in older women: A systematic review and meta-analysis. [PDF]
PLoS OneZhang J +5 more
europepmc +1 more source
TRPA1 promotes overactive bladder progression by activating the NLRP3 inflammasome and driving pyroptosis. [PDF]
Cell Death DisRao Y +6 more
europepmc +1 more source
Efficacy and Safety of Mirabegron Compared to Solifenacin in Treatment of Non-neurogenic Overactive Bladder in Children: A Randomized Controlled Trial. [PDF]
Int Braz J UrolMansour I +4 more
europepmc +1 more source
Evaluating the safety and effectiveness of α-blockers versus mirabegron for medical expulsive therapy in ureteral calculi: A Systematic review and meta-analysis. [PDF]
PLoS OneYan H +5 more
europepmc +1 more source
Efficacy of Solifenacin, Mirabegron, and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry): Protocol for a Randomized Single-Blinded Controlled Trial. [PDF]
JMIR Res ProtocSvendsen AM +6 more
europepmc +1 more source
Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek<sup>®</sup> in adult patients with overactive bladder. [PDF]
Investig Clin UrolPark JS +4 more
europepmc +1 more source
Enantioseparation of Mirabegron Using Cyclodextrin-based Chiral Columns: High-performance Liquid Chromatography and Molecular Modeling Study. [PDF]
J Sep SciMhammad A +5 more
europepmc +1 more source